Product Details
| Product Name: N-Nitroso Cyclophosphamide USP Related Compound A | CAS No.: 67856-68-2 |
| Min. Order: 1mg | Purity: >95% HPLC |
| Supply Ability: 100000 | Release date: 2025/07/31 |
| Molecular Formula:: C4H8Cl2N2O | Molecular Weight:: 171.02 |
| Appearance: Black liquid | Storage: 2-8°C Refrigerator |
| Product Catalog： | C094039 |
| CAS No.： | 67856-68-2 |
| Product Name： | N-Nitroso Cyclophosphamide USP Related Compound A |
| Purity： | >95% HPLC |
| Synonyms: | N,N-bis(2-chloroethyl)nitrous amide |
| Molecular Formula: | C4H8Cl2N2O |
| Mol. Weight： | 171.02 |
| Appearance: | Black liquid |
| Storage： | 2-8°C Refrigerator |
| Contact: | WhatsAPP: +86 17320513646 E-mail: anna@molcoo.com |
| Note: | We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS. This product is intended for laboratory use only! |
| Background: | N-Nitroso Cyclophosphamide USP Related Compound A is a nitrosated derivative associated with cyclophosphamide, a widely - used chemotherapy drug for treating various cancers. At present, the research on N-Nitroso Cyclophosphamide USP Related Compound A mainly focuses on the detection and control of impurities. Due to the potential carcinogenicity of nitrosamine impurities, global pharmaceutical regulatory authorities and the pharmaceutical industry have paid great attention to them. The United States Pharmacopeial Convention (USP) has issued and continuously updated relevant general chapters, and launched a variety of nitrosamine impurity reference standards and drug analysis impurities, including N-Nitroso Cyclophosphamide USP Related Compound A, to assist enterprises in detecting and controlling the levels of nitrosamine impurities in drugs. |
Company Profile Introduction
-
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2025-02-06 | |
| $0.00/25kg |
VIP1Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-06-19 | |
| $0.00/5mg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2025-02-18 |
ChinaINQUIRY